期刊
UROLOGY
卷 98, 期 -, 页码 14-20出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.urology.2016.08.013
关键词
-
资金
- Agency for Healthcare Research and Quality [HHSA2902012000071]
- U.S. Department of Health and Human Services
The management of clinically localized renal masses suspicious for renal cell carcinoma varies, partially because of gaps in the evidence base. We conducted a systematic review to summarize research gaps for the evaluation of composite models for predicting malignancy; use of percutaneous renal sampling for diagnosis; and comparative effectiveness of surgery, thermal ablation, and active surveillance. A total of 147 studies, published in 150 articles, were identified. To promote improved patient care and health outcomes, we recommend incorporation of emerging biomarkers into validated composite models, standardization of biopsy protocols, standard reporting of clinical stage, and performance of prospective studies with objective selection criteria. (C) 2016 Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据